10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To investigate the use of medroxyprogesterone acetate (MPA) to prevent LH surge during controlled ovarian hyperstimulation (COH) and to compare cycle characteristics and pregnancy outcomes in subsequently frozen-thawed ET (FET) cycles.

          Related collections

          Author and article information

          Journal
          Fertil. Steril.
          Fertility and sterility
          Elsevier BV
          1556-5653
          0015-0282
          Jul 2015
          : 104
          : 1
          Affiliations
          [1 ] Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China. Electronic address: Kuangyanp@126.com.
          [2 ] Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
          [3 ] Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel.
          Article
          S0015-0282(15)00227-7
          10.1016/j.fertnstert.2015.03.022
          25956370
          023c519d-f6ff-49c0-b297-0dbabb7089ce
          History

          premature LH surge,controlled ovarian stimulation,Medroxyprogesterone acetate

          Comments

          Comment on this article